Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Bialystok – page 28

579 clinical trials in Bialystok, Poland across 9 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Bialystok at a glance
579
clinical trials
  • Research sites9
Type of trial
Recruitment status
Quick filters

579 trials in Bialystok

Open in trial search

Schizophrenia

Not recruiting

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Iclepertin
  • Sponsor:Boehringer Ingelheim International GmbH

Psoriatic arthropathy

Not recruiting

Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Not Used Anti-TNF Therapy

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tildrakizumab
  • Sponsor:Iqvia Biotech Limited

Arteriosclerosis

Not recruiting

Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG

Study on Balcinrenone and Dapagliflozin for Adults with Chronic Kidney Disease and Albuminuria

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:AstraZeneca AB

Colitis ulcerative

Not recruiting

Study on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Asthma

Not recruiting

Study on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atuliflapon
  • Sponsor:AstraZeneca AB

Ischaemic stroke+2

Not recruiting

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG

Study on the Effectiveness of Weekly IcoSema (Insulin Icodec and Semaglutide) vs. Daily Insulin Glargine for Adults with Type 2 Diabetes Not Controlled by Oral Drugs

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Novo Nordisk A/S

Breast cancer

Not recruiting

Study of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC

Asthma

Not recruiting

Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:Chiesi Farmaceutici S.p.A.

Dermatitis atopic

Not recruiting

Study on the Effectiveness and Safety of Methotrexate Compared to Placebo for Adults with Moderate to Severe Atopic Dermatitis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Desoximetasone
  • Sponsor:Medac Gesellschaft fuer klinische Spezialpraeparate mbH

Gout

Not recruiting

Study on the Effects of Tigulixostat and Allopurinol in Patients with Gout and High Uric Acid Levels

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Allopurinol
  • Sponsor:LG Chem Ltd.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Bialystok

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on bladder cancer treatment using combination therapies, and innovative approaches for advanced breast cancer management. Research includes novel treatments for various solid tumors and gynecological malignancies.

  • Non-muscle invasive bladder cancer treatment
  • Advanced/metastatic breast cancer therapies
  • Gynecological tumor treatments

Investigations emphasize combination therapies and targeted treatment approaches.

02 Neurological & Mental Health

Clinical research targeting early Alzheimer's disease, exploring new treatments to slow disease progression and improve cognitive function.

  • Alzheimer's disease progression
  • Cognitive function assessment
  • Disease-modifying therapies

Focus on developing interventions for early-stage neurological conditions.

03 Inflammatory Conditions

Comprehensive studies on various inflammatory conditions including psoriatic arthritis, plaque psoriasis, and Crohn's disease. Research spans both biologic-naive and experienced patients.

  • Moderate to severe plaque psoriasis
  • Active psoriatic arthritis treatments
  • Chronic rhinosinusitis management

Evaluating novel therapeutic approaches for inflammatory disorders.

04 Metabolic & Cardiovascular Health

Studies addressing obesity, chronic kidney disease, and heart failure prevention. Research includes innovative treatments for weight management and cardiovascular risk reduction.

  • Obesity and weight management
  • Heart failure prevention
  • Chronic kidney disease treatments

Integration of multiple therapeutic approaches for complex metabolic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.